DOQCS database

NCBS Home page

Accession List

Pathway List

Authorized Users

Help

News archives

Enter a Search String

Special character and space not allowed in the query term. Search string should be at least 2 characters long.

Molecule List for Accession fig4_synapse (Accession Number3)

Default ordering is done according to Pathway Number. Table headers can be used for changing the default ordering.

arrow indicates that ordering is done according to ascending or descending order.
The entries are grouped according to Pathway Number and are alternately color coded using

and

color.

	Name	Pathway Name / Pathway No.	Accession Type	Initial Conc. (uM)	Volume (fL)	Buffered	Sum Total Of
1	AA	Shared_Object_ fig4_synapse Pathway No. 19	Network	0	1000	No	-
2	AC1	AC Pathway No. 31	Network	0.02	1000	No	-
3	AC1-CaM	AC Pathway No. 31	Network	0	1000	No	-
4	AC1-Gs	AC Pathway No. 31	Network	0	1000	No	-
5	AC2	AC Pathway No. 31	Network	0.015	1000	No	-
6	AC2*	AC Pathway No. 31	Network	0	1000	No	-
7	AC2*-Gs	AC Pathway No. 31	Network	0	1000	No	-
8	AC2-Gs	AC Pathway No. 31	Network	0	1000	No	-
9	AMP	AC Pathway No. 31	Network	325490	0.0016667	No	-
10	APC	PLA2 Pathway No. 21	Network	30	1000	Yes	-
11	ATP	AC Pathway No. 31	Network	5000	1000	Yes	-
12	BetaGamma	Shared_Object_ fig4_synapse Pathway No. 19	Network	0	1000	No	-
13	Blocked-rec-Gq	Gq Pathway No. 23	Network	0	1000	No	-
14	Ca	Shared_Object_ fig4_synapse Pathway No. 19	Network	0.08	1000	No	-
15	CaM	CaM Pathway No. 27	Network	20	1000	No	-
16	CaM(Ca)n-CaNAB	Shared_Object_ fig4_synapse Pathway No. 19	Network	0	1000	No	CaMCa4-CaNAB CaMCa3-CaNAB CaMCa2-CANAB
17	CaM-Ca3	Shared_Object_ fig4_synapse Pathway No. 19	Network	0	1000	No	-
18	CaM-Ca4	Shared_Object_ fig4_synapse Pathway No. 19	Network	0	1000	No	-
19	CaM-GEF	Ras Pathway No. 25	Network	0	1000	No	-
20	CaM-TR2-Ca2	Shared_Object_ fig4_synapse Pathway No. 19	Network	0	1000	No	-

Database compilation and code copyright (C) 2022, Upinder S. Bhalla and NCBS/TIFR
This Copyright is applied to ensure that the contents of this database remain freely available. Please see FAQ for details.